ReviewNature reviews. Clinical oncology2016
The influence of subclonal resistance mutations on targeted cancer therapy.
Michael W Schmitt et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
138 papers cite itlatest 60 shown
this papertrialcites it